Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease

Autor: Zifko, Udo, Schmiedlechner, Theresa, Saelens, Johan, Zifko, Katharina, Wagner, Michael, Assadian, Ojan, Grisold, Wolfgang, Stingl, Harald

Publikováno v: In Journal of the Neurological Sciences 15 June 2021 425

Reply to: Letter to the Editor – N. Mitchell; Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease

Autor: Zifko, Udo, Schmiedlechner, Theresa, Saelens, Johan, Zifko, Katharina, Wagner, Michael, Assadian, Ojan, Grisold, Wolfgang, Stingl, Harald

Publikováno v: In Journal of the Neurological Sciences 15 September 2021 428

Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics.

Autor: Kojic M; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Saelens J; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria., Kadriu B; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.; Department of Neuroscience, Janssen Research & Development, LLC, San Diego, CA, USA., Zarate CA Jr; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA., Kraus C; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria. christoph.kraus@muv.ac.at.; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. christoph.kraus@muv.ac.at.

Publikováno v: Current topics in behavioral neurosciences [Curr Top Behav Neurosci] 2022; Vol. 56, pp. 141-167.